Oxbridge Re Holdings Limited (OXBR) 10-Year Financial Performance & Capital Metrics

OXBR • • Insurance & Managed Care

Financial ServicesReinsuranceProperty & Casualty ReinsuranceRegional & Niche Property Reinsurers

AboutOxbridge Re Holdings Limited, together with its subsidiaries, provides specialty property and casualty reinsurance solutions. It underwrites reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. The company distributes its products and solutions through reinsurance brokers. Oxbridge Re Holdings Limited was incorporated in 2013 and is headquartered in George Town, the Cayman Islands.Show more

Revenue $546K +107.7%
Combined Ratio 397.62% +1383.9%
Net Income -$2M +82.2%
Return on Equity -37.36% +61.7%
Medical Cost Ratio 46.52%
Operating Margin -297.62% -327.2%
Net Margin -323.08% -329.7%
ROA -22.45% +71.9%
Equity / Assets 55.06% -14.8%
Book Value per Share 0.67 -25.8%
Tangible BV/Share 0.67 -24.4%
Debt/Equity 0.06 +171.7%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Low loss ratio of 46.5%

✗Weaknesses

✗Unprofitable underwriting: 397.6% combined ratio
✗Weak Piotroski F-Score: 3/9
✗Weak momentum: RS Rating 14 (bottom 14%)
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-20.71%

5Y-11.06%

3Y-62.34%

TTM236.05%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM22.07%

EPS CAGR

10Y-

5Y-

3Y-

TTM56.42%

ROCE

10Y Avg-12.93%

5Y Avg-7.9%

3Y Avg-35.03%

Latest-20.68%

Peer Comparison

Regional & Niche Property Reinsurers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
KGKestrel Group, Ltd.	73.01M	9.43	-0.23	294.7%	-370.55%	-70.78%		5.65
OXBROxbridge Re Holdings Limited	9.42M	1.23	-2.73	107.75%	-128.35%	-45.24%		0.06

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	6.38M	19.06M	23.84M	3.8M	981K	1.21M	10.22M	850K	-7.05M	546K
Revenue Growth %	0.15%	1.99%	0.25%	-0.84%	-0.74%	0.24%	7.42%	-0.92%	-9.29%	1.08%
Medical Costs & Claims+	344K	15.06M	43.11M	10.27M	64K	98K	264K	1.18M	0	254K
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-	-
Gross Profit+	6.04M	4M	-19.27M	-6.47M	917K	1.12M	9.96M	-333K	-7.05M	292K
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	0.18%	-0.34%	-5.82%	0.66%	1.14%	0.22%	7.93%	-1.03%	-20.17%	1.04%
Operating Expenses+	1.44M	1.42M	1.32M	1.28M	1.07M	1.03M	1.3M	1.41M	2.18M	1.92M
OpEx / Revenue %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	18K	21K	24K	18K	10K	10K	7K	4K	6K	3K
Combined Ratio %	-	-	-	-	-	-	-	-	-	-
Operating Income+	4.6M	2.58M	-20.59M	-7.75M	-150K	88K	8.66M	-1.75M	-9.23M	-1.63M
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	0.15%	-0.44%	-8.98%	0.62%	0.98%	1.59%	97.36%	-1.2%	-4.29%	0.82%
EBITDA+	4.62M	2.6M	-20.57M	-7.73M	-140K	98K	8.66M	-1.74M	-9.23M	-1.62M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense	0	0	0	0	0	0	0	0	0	0
Non-Operating Income	0	0	0	0	0	0	0	0	141K	0
Pretax Income+	4.6M	2.58M	-20.59M	-7.75M	-150K	88K	8.66M	-1.75M	-9.37M	-1.63M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	0	0	0	0	0	0	0	0	542K	0
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	4.6M	2.58M	-20.59M	-7.75M	-150K	88K	8.66M	-1.75M	-9.91M	-1.76M
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	0.15%	-0.44%	-8.98%	0.62%	0.98%	1.59%	97.36%	-1.2%	-4.68%	0.82%
EPS (Diluted)+	0.76	0.43	-3.55	-1.00	-0.03	0.02	1.49	-0.61	-1.69	-0.45
EPS Growth %	-0.07%	-0.43%	-9.26%	0.72%	0.97%	1.58%	96.39%	-1.41%	-1.77%	0.73%
EPS (Basic)	0.76	0.43	-3.55	-1.00	-0.03	0.02	1.49	-0.61	-1.69	-0.45
Diluted Shares Outstanding	6.06M	6.02M	5.8M	5.73M	5.73M	5.73M	5.74M	5.77M	5.87M	6.1M

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	52.69M	51M	21.39M	12.56M	9.49M	9.08M	17.69M	16.62M	8.25M	7.46M
Asset Growth %	0.06%	-0.03%	-0.58%	-0.41%	-0.24%	-0.04%	0.95%	-0.06%	-0.5%	-0.1%
Total Investment Assets+	9.35M	10.99M	6.47M	1.16M	692K	787K	11.75M	12.06M	0	161K
Long-Term Investments	9.35M	10.99M	6.47M	1.16M	692K	787K	11.75M	12.06M	0	161K
Short-Term Investments	9.35M	10.99M	6.47M	993K	0	0	0	0	0	0
Total Current Assets+	12.73M	16.33M	11.6M	9.08M	0	0	0	0	5.38M	0
Cash & Equivalents	8.58M	12.24M	7.76M	8.07M	5.96M	5.56M	3.53M	1.21M	495K	2.13M
Receivables	0	0	1000K	15K	518K	465K	289K	327K	977K	1000K
Other Current Assets	0	0	0	0	-6.56M	-6.1M	-3.87M	-1.67M	3.91M	-3.19M
Goodwill & Intangibles+	90K	88K	48K	0	0	0	0	0	101K	0
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	90K	88K	48K	0	0	0	0	0	101K	0
PP&E (Net)	64K	54K	36K	18K	142K	235K	144K	49K	13K	149K
Other Assets	43.27M	39.95M	14.89M	11.39M	-834K	-1.02M	-11.89M	-12.11M	3.25M	-310K
Total Liabilities	15.66M	13.84M	7.47M	4.25M	1.45M	1.06M	1.04M	1.63M	2.92M	3.35M
Total Debt+	0	0	0	0	733K	438K	351K	260K	127K	266K
Net Debt	-8.58M	-12.24M	-7.76M	-8.07M	-5.23M	-5.12M	-3.18M	-947K	-368K	-1.87M
Long-Term Debt	0	0	0	0	600K	216K	216K	216K	118K	118K
Short-Term Debt	0	0	0	0	0	0	0	0	0	0
Total Current Liabilities+	176K	204K	106K	139K	0	0	0	0	0	0
Accounts Payable	176K	204K	106K	139K	279K	209K	337K	294K	356K	0
Deferred Revenue	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	-9.91M	-1.47M	-627K	-139K	-279K	-209K	-337K	-294K	-1.88M	-1.73M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0
Other Liabilities	0	13.84M	7.47M	4.25M	-733K	-438K	-351K	-260K	2.79M	-266K
Total Equity+	37.03M	37.16M	13.92M	8.31M	8.04M	8.03M	16.65M	14.99M	5.33M	4.11M
Equity Growth %	0.01%	0%	-0.63%	-0.4%	-0.03%	-0%	1.07%	-0.1%	-0.64%	-0.23%
Shareholders Equity	37.03M	37.16M	13.92M	8.31M	8.04M	8.03M	16.65M	14.99M	5.33M	3.95M
Minority Interest	0	0	0	0	0	0	0	0	0	162K
Retained Earnings	4.84M	4.53M	-18.15M	-23.92M	-24.23M	-24.27M	-15.71M	-17.5M	-27.41M	-30.16M
Common Stock	6K	6K	6K	6K	6K	6K	6K	6K	6K	6K
Accumulated OCI	-1.47M	-411K	-39K	2K	0	0	0	0	0	0
Return on Equity (ROE)	0.12%	0.07%	-0.81%	-0.7%	-0.02%	0.01%	0.7%	-0.11%	-0.98%	-0.37%
Return on Assets (ROA)	0.09%	0.05%	-0.57%	-0.46%	-0.01%	0.01%	0.65%	-0.1%	-0.8%	-0.22%
Equity / Assets	-	-	-	-	-	-	-	-	-	-
Debt / Equity	-	-	-	-	0.09x	0.05x	0.02x	0.02x	0.02x	0.06x
Book Value per Share	6.11	6.17	2.40	1.45	1.40	1.40	2.90	2.60	0.91	0.67
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	8.13M	416K	-26.31M	-6.63M	-4.37M	-266K	-253K	-829K	-1.26M	-1.23M
Operating CF Growth %	-0.06%	-0.95%	-64.25%	0.75%	0.34%	0.94%	0.05%	-2.28%	-0.52%	0.02%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	4.6M	2.58M	-20.59M	-5.75M	-305K	-50K	8.56M	-1.79M	-9.91M	-2.73M
Depreciation & Amortization	18K	21K	24K	18K	10K	10K	7K	4K	6K	3K
Stock-Based Compensation	117K	119K	127K	126K	36K	32K	61K	127K	258K	234K
Deferred Taxes	208K	-673K	0	288K	0	0	0	0	0	0
Other Non-Cash Items	516K	140K	222K	-2M	-28K	-219K	-9.16M	346K	8.61M	2.14M
Working Capital Changes	2.67M	-1.77M	-6.09M	684K	-4.08M	-39K	275K	483K	-216K	-887K
Cash from Investing+	-1.95M	6.87M	24.98M	5.04M	488K	110K	-1.8M	-661K	-105K	780K
Capital Expenditures	-36K	-11K	-6K	0	-1K	-14K	-3K	0	-5K	0
Acquisitions	0	0	0	0	0	0	1.8M	626K	0	0
Purchase of Investments	-13.13M	-13.13M	-22.65M	-10.91M	-505K	-2.59M	-3.15M	-1.29M	0	0
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	994K	1000K	1000K	626K	0	307K
Other Investing	-2.19M	6.93M	20.32M	5.04M	0	0	-1.8M	-626K	-100K	473K
Cash from Financing+	-2.91M	-3.63M	-3.15M	2M	600K	-384K	-1K	0	1.18M	2.6M
Dividends Paid	-2.91M	-2.88M	-2.09M	-35K	0	0	-1K	0	0	0
Share Repurchases	0	-742K	-1.06M	0	0	0	0	0	0	0
Stock Issued	0	0	0	0	0	0	0	0	0	1.13M
Debt Issuance (Net)	0	0	0	1000K	600K	-384K	0	0	1000K	1000K
Other Financing	0	0	0	0	0	0	1K	0	0	0
Net Change in Cash+	3.27M	3.66M	-4.48M	412K	-3.28M	-540K	-2.06M	-1.49M	-183K	2.15M
Exchange Rate Effect	0	0	0	0	0	0	1K	0	0	0
Cash at Beginning	5.32M	8.58M	12.24M	10.89M	11.3M	8.02M	7.48M	5.42M	3.93M	3.75M
Cash at End	8.58M	12.24M	7.76M	11.3M	8.02M	7.48M	5.42M	3.93M	3.75M	5.89M
Free Cash Flow+	8.09M	405K	-26.32M	-6.63M	-4.37M	-280K	-256K	-829K	-1.26M	-1.23M
FCF Growth %	-0.06%	-0.95%	-65.98%	0.75%	0.34%	0.94%	0.09%	-2.24%	-0.53%	0.03%
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF per Share	1.34	0.07	-4.54	-1.16	-0.76	-0.05	-0.04	-0.14	-0.22	-0.2

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Combined Ratio	27.88%	86.46%	186.37%	303.81%	115.29%	92.75%	15.34%	305.41%	-30.97%	397.62%
Medical Cost Ratio	5.39%	79.01%	180.81%	270.09%	6.52%	8.07%	2.58%	139.18%	0%	46.52%
Return on Equity (ROE)	12.48%	6.96%	-80.62%	-69.71%	-1.83%	1.1%	70.16%	-11.04%	-97.58%	-37.36%
Return on Assets (ROA)	8.99%	4.98%	-56.89%	-45.64%	-1.36%	0.95%	64.66%	-10.18%	-79.74%	-22.45%
Equity / Assets	70.28%	72.87%	65.06%	66.19%	84.71%	88.35%	94.13%	90.21%	64.61%	55.06%
Book Value / Share	6.11	6.17	2.4	1.45	1.4	1.4	2.9	2.6	0.91	0.67
Debt / Equity	-	-	-	-	0.09x	0.05x	0.02x	0.02x	0.02x	0.06x
Revenue Growth	14.77%	198.78%	25.07%	-84.05%	-74.2%	23.75%	742.26%	-91.69%	-929.29%	107.75%

Revenue by Segment

	2014	2022
Property, Liability and Casualty Insurance Product Line	4.82M	995K
Property, Liability and Casualty Insurance Product Line Growth	-	-79.35%

Frequently Asked Questions

Growth & Financials

Oxbridge Re Holdings Limited (OXBR) grew revenue by 107.7% over the past year. This is strong growth.

Oxbridge Re Holdings Limited (OXBR) reported a net loss of $3.1M for fiscal year 2024.

Dividend & Returns

Oxbridge Re Holdings Limited (OXBR) has a return on equity (ROE) of -37.4%. Negative ROE indicates the company is unprofitable.

Industry Metrics

Oxbridge Re Holdings Limited (OXBR) has a combined ratio of 397.6%. A ratio above 100% means claims and expenses exceed premiums.

← Back to Screener